TAUB MALCOLM S 4
4 · BRAINSTORM CELL THERAPEUTICS INC. · Filed Nov 30, 2018
Insider Transaction Report
Form 4
TAUB MALCOLM S
Director
Transactions
- Award
Common Stock
2018-11-30+12,000→ 41,332 total
Footnotes (1)
- [F1]Shares acquired are shares of restricted stock awarded on November 30, 2018 pursuant to the Brainstorm Cell Therapeutics Inc. Second Amended and Restated Director Compensation Plan. The shares of restricted stock vest in 12 consecutive, equal monthly installments commencing on December 30, 2018 until fully vested on the first anniversary of the date of grant, provided that the reporting person remains a director of Brainstorm Cell Therapeutics on each vesting date.